{"id":"https://openalex.org/W2098037832","doi":"https://doi.org/10.1530/eje.1.02219","title":"Short-term administration of an angiotensin-receptor antagonist in patients with impaired fasting glucose improves insulin sensitivity and increases free IGF-I","display_name":"Short-term administration of an angiotensin-receptor antagonist in patients with impaired fasting glucose improves insulin sensitivity and increases free IGF-I","publication_year":2006,"publication_date":"2006-07-25","ids":{"openalex":"https://openalex.org/W2098037832","doi":"https://doi.org/10.1530/eje.1.02219","mag":"2098037832","pmid":"https://pubmed.ncbi.nlm.nih.gov/16868143"},"language":"en","primary_location":{"id":"doi:10.1530/eje.1.02219","doi":"https://doi.org/10.1530/eje.1.02219","is_oa":false,"landing_page_url":"https://doi.org/10.1530/eje.1.02219","pdf_url":null,"source":{"id":"https://openalex.org/S4210218062","display_name":"European Journal of Endocrinology","issn_l":"0804-4643","issn":["0804-4643","1479-683X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Endocrinology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090892013","display_name":"Adrienne A.M. Zandbergen","orcid":"https://orcid.org/0000-0001-5056-5921","observed_orcids":["https://orcid.org/0000-0001-5056-5921"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Adrienne A M Zandbergen","raw_affiliation_strings":["Department of Internal Medicine, Erasmus University Medical Centre, Dr Molewaterplein 40 3015 GD Rotterdam, The Netherlands. adrienne_zandbergen@yahoo.com","Department of Internal Medicine, Erasmus University Medical Centre, Dr Molewaterplein 40 3015 GD Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Erasmus University Medical Centre, Dr Molewaterplein 40 3015 GD Rotterdam, The Netherlands. adrienne_zandbergen@yahoo.com","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"Department of Internal Medicine, Erasmus University Medical Centre, Dr Molewaterplein 40 3015 GD Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113453092","display_name":"Steven W. J. Lamberts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Steven W J Lamberts","raw_affiliation_strings":["Department of Internal Medicine, Erasmus University Medical Centre, Dr Molewaterplein 40 3015 GD Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Erasmus University Medical Centre, Dr Molewaterplein 40 3015 GD Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026436166","display_name":"J. A. M. J. L. Janssen","orcid":"https://orcid.org/0000-0002-9363-6408","observed_orcids":["https://orcid.org/0000-0002-9363-6408"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Joop A M J L Janssen","raw_affiliation_strings":["Department of Internal Medicine, Erasmus University Medical Centre, Dr Molewaterplein 40 3015 GD Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Erasmus University Medical Centre, Dr Molewaterplein 40 3015 GD Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110027409","display_name":"Aart H. Bootsma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Aart H Bootsma","raw_affiliation_strings":["Department of Internal Medicine, Erasmus University Medical Centre, Dr Molewaterplein 40 3015 GD Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Erasmus University Medical Centre, Dr Molewaterplein 40 3015 GD Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2801952686"],"apc_list":{"value":3798,"currency":"EUR","value_usd":4292},"apc_paid":null,"fwci":1.5853,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.85332631,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"155","issue":"2","first_page":"293","last_page":"296"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.8496000170707703,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.8496000170707703,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.09860000014305115,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.01759999990463257,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":0.9959999918937683},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.7630000114440918},{"id":"https://openalex.org/keywords/renin-angiotensin-system","display_name":"renin-angiotensin system","score":0.9549999833106995},{"id":"https://openalex.org/keywords/impaired-fasting-glucose","display_name":"impaired fasting glucose","score":0.949999988079071},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9100000262260437},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.8019999861717224},{"id":"https://openalex.org/keywords/free-igf-i","display_name":"free IGF-I","score":0.9729999899864197},{"id":"https://openalex.org/keywords/igf-binding-protein-3","display_name":"IGF binding protein-3","score":0.9309999942779541},{"id":"https://openalex.org/keywords/type-2-diabetes-prevention","display_name":"type 2 diabetes prevention","score":0.9610000252723694},{"id":"https://openalex.org/keywords/glucose-homeostasis","display_name":"glucose homeostasis","score":0.9599999785423279}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8811176419258118},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.8664069771766663},{"id":"https://openalex.org/C3017594256","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin sensitivity","level":4,"score":0.7223122119903564},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5694184899330139},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5104902982711792},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.48114144802093506},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.47631701827049255},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.43655213713645935},{"id":"https://openalex.org/C61797465","wikidata":"https://www.wikidata.org/wiki/Q1188986","display_name":"Term (time)","level":2,"score":0.42717593908309937},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.28192082047462463},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D005215","descriptor_name":"Fasting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D007334","descriptor_name":"Insulin-Like Growth Factor I","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018149","descriptor_name":"Glucose Intolerance","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018149","descriptor_name":"Glucose Intolerance","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1530/eje.1.02219","doi":"https://doi.org/10.1530/eje.1.02219","is_oa":false,"landing_page_url":"https://doi.org/10.1530/eje.1.02219","pdf_url":null,"source":{"id":"https://openalex.org/S4210218062","display_name":"European Journal of Endocrinology","issn_l":"0804-4643","issn":["0804-4643","1479-683X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Endocrinology","raw_type":"journal-article"},{"id":"pmid:16868143","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16868143","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of endocrinology","raw_type":"Clinical Trial"},{"id":"pmh:eur:oai:pure.eur.nl:publications/7b124539-a0e4-434f-a09b-7017101dfc2d","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/7b124539-a0e4-434f-a09b-7017101dfc2d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Endocrinology, 155(2), 293 - 296. Bioscientifica Ltd","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/7b124539-a0e4-434f-a09b-7017101dfc2d","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1765/56727","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Zandbergen, AAM, Lamberts, S W J, Janssen, J A M J L & Bootsma, AH 2006, 'Short-term administration of an angiotensin-receptor antagonist in patients with impaired fasting glucose improves insulin sensitivity and increases free IGF-I', European Journal of Endocrinology, vol. 155, no. 2, pp. 293-296. https://doi.org/10.1530/eje.1.02219","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W116867690","https://openalex.org/W1971875889","https://openalex.org/W2018431713","https://openalex.org/W2035155857","https://openalex.org/W2038686627","https://openalex.org/W2055427232","https://openalex.org/W2093424366","https://openalex.org/W2097288698","https://openalex.org/W2134293572","https://openalex.org/W2140997600","https://openalex.org/W2144030806","https://openalex.org/W2172032309","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W1698169390","https://openalex.org/W2077576711","https://openalex.org/W2139178589","https://openalex.org/W2081275762","https://openalex.org/W2099382390","https://openalex.org/W2015836575","https://openalex.org/W2388972994","https://openalex.org/W7095075355","https://openalex.org/W1963957614","https://openalex.org/W2413327341"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Blocking":[1],"the":[2,8,19,30,41,44,77,85,96,124,127,141,168,174,188,219,240,249],"renin-angiotensin":[3],"system":[4],"(RAS)":[5],"may":[6],"reduce":[7],"risk":[9],"of":[10,43,89,100,109,153,166,170,212,221,239,242,251],"developing":[11],"type-2":[12,243],"diabetes,":[13],"but":[14],"data":[15],"are":[16,22],"inconclusive":[17],"and":[18,25,51,75,111,118,140],"mechanisms":[20],"involved":[21],"unclear.":[23],"RAS":[24,26],"inhibition":[27],"also":[28],"influence":[29],"IGF-I":[31,52,155,178],"system,":[32],"which":[33,215],"is":[34],"important":[35],"in":[36,176,187,200,232,254],"glucose":[37,66,101],"homeostasis.":[38],"We":[39],"investigated":[40],"effects":[42],"angiotensin-receptor":[45,252],"antagonist,":[46],"losartan,":[47],"on":[48],"insulin":[49,80,90,131,222],"resistance":[50,91,132,223],"levels":[53,108,152,179,211],"DESIGN":[54],"AND":[55],"METHODS:":[56],"In":[57,164],"this":[58],"hypothesis-generating":[59],"study,":[60],"five":[61],"individuals":[62],"with":[63,102,173,193,225],"impaired":[64],"fasting":[65],"received":[67],"100":[68],"mg":[69],"losartan":[70,226],"during":[71],"8":[72],"weeks.":[73],"Before":[74],"after":[76],"treatment":[78,125],"period,":[79,126],"sensitivity":[81],"was":[82,191],"assessed":[83],"using":[84],"homeostasis":[86],"model":[87,103],"assessment":[88,104],"(HOMA),":[92],"as":[93,95,246,248],"well":[94,247],"2-h":[97,142,194],"continuous":[98],"infusion":[99],"(CIGMA).":[105],"Furthermore,":[106],"serum":[107,151,210],"free":[110,154,177,213],"total":[112,202],"IGF-I,":[113,203,214],"IGF-binding":[114],"protein-3":[115],"(IGFBP-3),":[116],"lipids":[117],"HbAlc":[119],"were":[120,198],"measured.":[121],"RESULTS:":[122],"After":[123],"HOMA":[128,171],"score":[129,144],"for":[130],"had":[133,156],"decreased":[134],"from":[135,145,158],"5.3+/-1.1":[136],"to":[137,147,160,218],"3.7+/-0.9":[138],"(P=0.004)":[139],"CIGMA":[143],"23.4+/-3.1":[146],"15.9+/-2.1":[148],"(P=0.07).":[149],"The":[150],"increased":[157],"57+/-18.8":[159],"134+/-31.3":[161],"pmol/l":[162],"(P=0.04).":[163],"terms":[165],"percentage,":[167],"decrease":[169],"correlated":[172],"increase":[175],"(Pearson's":[180],"correlation":[181],"coefficient":[182],"r=-0.8;":[183],"P=0.07).":[184],"A":[185],"trend":[186],"same":[189],"direction":[190],"observed":[192,199],"CIGMA.":[195],"No":[196],"differences":[197],"lipids,":[201],"IGFBP-3":[204],"or":[205],"HbAlc.":[206],"CONCLUSIONS:":[207],"Losartan":[208],"raised":[209],"might":[216],"contribute":[217],"improvement":[220],"associated":[224],"treatment.":[227],"These":[228],"observations,":[229],"if":[230],"confirmed":[231],"broader":[233],"studies,":[234],"will":[235],"help":[236],"our":[237],"understanding":[238],"pathogenesis":[241],"diabetes":[244],"mellitus,":[245],"role":[250],"antagonists":[253],"its":[255],"prevention.":[256]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}